Plasma Concentrations, Efficacy and Safety of Efavirenz in HIV-Infected Adults Treated for Tuberculosis in Cambodia (ANRS 1295-CIPRA KH001 CAMELIA Trial)

OBJECTIVE: To assess efavirenz plasma concentrations and their association with treatment efficacy and tolerance of efavirenz 600 mg daily in HIV-tuberculosis co-infected patients. METHODS: HIV-infected adults with CD4+ T cell count ≤200/mm(3) received standard 6-month tuberculosis treatment and ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Borand, Laurence, Madec, Yoann, Laureillard, Didier, Chou, Monidarin, Marcy, Olivier, Pheng, Phearavin, Prak, Narom, Kim, Chindamony, Lak, Khemarin Kim, Hak, Chanroeun, Dim, Bunnet, Nerrienet, Eric, Fontanet, Arnaud, Sok, Thim, Goldfeld, Anne E., Blanc, François-Xavier, Taburet, Anne-Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946522/
https://www.ncbi.nlm.nih.gov/pubmed/24608960
http://dx.doi.org/10.1371/journal.pone.0090350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946522/
https://www.ncbi.nlm.nih.gov/pubmed/24608960
http://dx.doi.org/10.1371/journal.pone.0090350

Ejemplares similares